Clinical Trials
118
Participants
Perioperative Pregabalin in Ureteroscopy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2020-06-01
Completion:
2023-07-01
Conditions
Kidney Stone
Pain, Postoperative
Addiction
Opioid Use
Interventions
DRUG
61
Participants
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-11-14
Completion:
2026-09-30
Conditions
Metastatic Breast Cancer
Interventions
DRUG
No Results Yet
8800
Participants
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2020-08-25
Completion:
2026-01-31
Conditions
Shock
Septic
Interventions
DRUG
No Results Yet
316
Participants
A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-11-20
Completion:
2023-12-04
Conditions
Advanced Solid Tumor
Interventions
DRUG
Copper Histidinate Treatment for Menkes Disease
Study Type:
EXPANDED_ACCESS
Last Updated:
2025-11-12
Conditions
Menkes Disease
Interventions
DRUG
No Results Yet
665
Participants
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-08-12
Completion:
2028-05-12
Conditions
Myelodysplastic Syndromes (MDS)
Beta-thalassemia
Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Interventions
DRUG
No Results Yet
1064
Participants
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-09-26
Completion:
2023-09-19
Conditions
Ulcerative Colitis
Interventions
DRUG
75
Participants
A Center Based Early Intervention Program For Preschoolers With Developmental Disorders
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-10-19
Completion:
2034-12-30
Conditions
Development Disorder, Child
Developmental Disability
Development Delay
Autism Spectrum Disorder
Interventions
BEHAVIORAL
No Results Yet
301
Participants
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-07-11
Completion:
2027-08-31
Conditions
Endometrial Neoplasms
Neoplasms
Carcinoma, Hepatocellular
Liver Neoplasms
Colorectal Neoplasms
Interventions
DRUG
No Results Yet
32
Participants
Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-10-24
Completion:
2030-01-30
Conditions
Myeloid Chimerism
Interventions
DEVICE
No Results Yet
249
Participants
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-08-09
Completion:
2023-09-19
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IIIA Breast Cancer AJCC v8
Anatomic Stage IIIB Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Invasive Breast Carcinoma
Prognostic Stage I Breast Cancer AJCC v8
Prognostic Stage IA Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Prognostic Stage IIB Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Prognostic Stage IIIB Breast Cancer AJCC v8
Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
DRUG
OTHER
186
Participants
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-05-30
Completion:
2027-11-01
Conditions
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Interventions
RADIATION
OTHER
No Results Yet
400
Participants
Reproductive Axis Maturation in the Early Post-Menarchal Years
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-12
Start Date:
2019-12-19
Completion:
2029-07-01
Conditions
Reproductive Physiological Processes
Pediatrics
Adolescent Health
Adolescent Development
No Results Yet
26
Participants
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2020-01-10
Completion:
2024-12-26
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Breast Ductal Carcinoma In Situ
Breast Fibrocystic Change
Breast Lobular Carcinoma In Situ
Invasive Breast Carcinoma
Prognostic Stage I Breast Cancer AJCC v8
Prognostic Stage IA Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Prognostic Stage IIB Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Prognostic Stage IIIB Breast Cancer AJCC v8
Prognostic Stage IIIC Breast Cancer AJCC v8
Triple-Negative Breast Carcinoma
Interventions
DRUG
PROCEDURE
No Results Yet
40
Participants
Syndesmosis Ankle Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-10-15
Completion:
2023-10-26
Conditions
Syndesmotic Disruption
Weight-bearing Status
Interventions
OTHER
No Results Yet
80
Participants
Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-05-13
Completion:
2024-09-24
Conditions
Pain
Interventions
DRUG
91
Participants
Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-07-15
Completion:
2025-09-01
Conditions
Alcohol Use Disorder
Interventions
BEHAVIORAL
No Results Yet
26
Participants
Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-06-20
Completion:
2025-09-28
Conditions
Stage IIB Non-Small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IIIC Non-Small Cell Lung Cancer
Interventions
DEVICE
RADIATION
DRUG
BIOLOGICAL
No Results Yet
14
Participants
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-06-08
Completion:
2025-10-10
Conditions
Tumor, Solid
Interventions
DRUG
No Results Yet
994
Participants
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-08-29
Completion:
2024-03-31
Conditions
Ann Arbor Stage III Hodgkin Lymphoma
Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma
Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma
Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma
Ann Arbor Stage IV Hodgkin Lymphoma
Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma
Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma
Ann Arbor Stage IV Nodular Sclerosis Classic Hodgkin Lymphoma
Classic Hodgkin Lymphoma
Lymphocyte-Rich Classic Hodgkin Lymphoma
Interventions
PROCEDURE
DRUG
BIOLOGICAL
OTHER
RADIATION
15
Participants
IV Lidocaine in Pediatric AIS
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-07-30
Completion:
2024-12-31
Conditions
Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery
Interventions
DRUG
211
Participants
Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2020-06-16
Completion:
2025-09-01
Conditions
Alcohol Use Disorder
Interventions
BEHAVIORAL
No Results Yet
25
Participants
A Study of Esomeprazole in Children With Autism
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-05-29
Completion:
2028-12-31
Conditions
Autism
Autism Spectrum Disorder
Interventions
DRUG
No Results Yet
24
Participants
Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2021-10-11
Completion:
2025-04-01
Conditions
Mild Traumatic Brain Injury
Vestibular Neuropathy
Interventions
DEVICE
BEHAVIORAL
No Results Yet
34
Participants
Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-12
Start Date:
2019-02-05
Completion:
2021-01-19
Conditions
Hodgkin Disease
No Results Yet
3062
Participants
Sleep for Stroke Management and Recovery Trial
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-05-09
Completion:
2026-11-30
Conditions
Ischemic Stroke
Sleep Apnea
Sleep Apnea, Obstructive
Stroke
CPAP
Telemedicine
Home Sleep Apnea Test
Randomized Clinical Trial
Multicenter Trial
Interventions
DEVICE
No Results Yet
636
Participants
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-08-16
Completion:
2027-01-01
Conditions
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Interventions
PROCEDURE
DRUG
OTHER
RADIATION
BIOLOGICAL
No Results Yet
500
Participants
Men at High Genetic Risk for Prostate Cancer
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-12
Start Date:
2019-03-27
Completion:
2029-01-01
Conditions
Prostatic Neoplasms
No Results Yet
620
Participants
Healthy Eating and Active Living Taught at Home (HEALTH) Dissemination & Implementation (D&I)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-01-25
Completion:
2024-07-31
Conditions
Obesity
Interventions
BEHAVIORAL
40
Participants
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-01-07
Completion:
2022-05-01
Conditions
Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Cervical Squamous Cell Carcinoma
Stage IB2 Cervical Cancer AJCC v8
Stage II Cervical Cancer AJCC v8
Stage IIA Cervical Cancer AJCC v8
Stage IIA1 Cervical Cancer AJCC v8
Stage IIA2 Cervical Cancer AJCC v8
Stage IIB Cervical Cancer AJCC v8
Stage IIIB Cervical Cancer AJCC v8
Stage IVA Cervical Cancer AJCC v8
Interventions
DRUG
RADIATION
40
Participants
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2018-10-01
Completion:
2026-12-31
Conditions
Renal Failure Congenital
Congenital Renal Anomaly Nos
Renal Agenesis and Dysgenesis
Lower Urinary Tract Obstructive Syndrome
Interventions
DRUG
No Results Yet
288
Participants
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2018-09-27
Completion:
2024-12-06
Conditions
Endometrial Adenocarcinoma
Endometrial Mixed Cell Adenocarcinoma
Endometrial Serous Adenocarcinoma
Endometrial Undifferentiated Carcinoma
Endometrioid Adenocarcinoma
Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Interventions
PROCEDURE
DRUG
BIOLOGICAL
139
Participants
A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2018-10-29
Completion:
2022-09-07
Conditions
Neoplasms by Site
Interventions
BIOLOGICAL
DRUG
1055
Participants
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2018-07-12
Completion:
2025-07-17
Conditions
Multiple Sclerosis
Interventions
DRUG
No Results Yet
15
Participants
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-01-08
Completion:
2024-09-30
Conditions
Metastatic Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
TFE3-Rearranged Renal Cell Carcinoma
Unresectable Renal Cell Carcinoma
Interventions
DRUG
BIOLOGICAL
22
Participants
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-03-13
Completion:
2027-05-03
Conditions
FLT3-mutated Acute Myeloid Leukemia
Interventions
DRUG
No Results Yet
15
Participants
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2019-01-11
Completion:
2025-12-01
Conditions
Bladder Small Cell Neuroendocrine Carcinoma
Castration-Resistant Prostate Carcinoma
Metastatic Bladder Urothelial Carcinoma
Metastatic Urethral Urothelial Carcinoma
Prostate Carcinoma Metastatic in the Bone
Prostate Neuroendocrine Neoplasm
Prostate Small Cell Carcinoma
Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v8
Stage III Prostate Cancer AJCC v8
Stage III Urethral Cancer AJCC v8
Stage IV Bladder Cancer AJCC v8
Stage IV Prostate Cancer AJCC v8
Stage IV Urethral Cancer AJCC v8
Stage IVA Bladder Cancer AJCC v8
Stage IVB Bladder Cancer AJCC v8
Ureter Small Cell Carcinoma
Urothelial Carcinoma
Interventions
DRUG
BIOLOGICAL
800
Participants
Study of the Safety and Effectiveness of Motiva Implants®
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2018-04-06
Completion:
2032-08-30
Conditions
Breast Implants
Interventions
DEVICE
No Results Yet
19
Participants
A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2018-08-31
Completion:
2019-07-09
Conditions
Prostatic Neoplasms
Interventions
DRUG
No Results Yet
565
Participants
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-12
Start Date:
2018-06-11
Completion:
2023-12-31
Conditions
Stage I Colon Cancer AJCC v8
Stage I Rectal Cancer AJCC v8
Stage II Colon Cancer AJCC v8
Stage II Rectal Cancer AJCC v8
Stage IIA Colon Cancer AJCC v8
Stage IIA Rectal Cancer AJCC v8
Stage IIB Colon Cancer AJCC v8
Stage IIB Rectal Cancer AJCC v8
Stage IIC Colon Cancer AJCC v8
Stage IIC Rectal Cancer AJCC v8
Stage III Colon Cancer AJCC v8
Stage III Rectal Cancer AJCC v8
Stage IIIA Colon Cancer AJCC v8
Stage IIIA Rectal Cancer AJCC v8
Stage IIIB Colon Cancer AJCC v8
Stage IIIB Rectal Cancer AJCC v8
Stage IIIC Colon Cancer AJCC v8
Stage IIIC Rectal Cancer AJCC v8
Interventions
OTHER
Showing 40 trials per page · Total 557382 trials